Diagnóstico y manejo de la rosácea: enfoques terapéuticos actuales
DOI:
https://doi.org/10.56183/iberojhr.v5i2.776Palavras-chave:
Rosácea, Diagnóstico, Manejo, Diagnóstico diferencial, Fenotipos, Cuidados de la piel.Resumo
La rosácea es una enfermedad crónica de la piel que afecta principalmente el rostro, caracterizada por enrojecimiento, pápulas, pústulas y, en algunos casos, engrosamiento de la piel. Su etiología aún no está completamente comprendida, aunque se han identificado factores genéticos, ambientales y disfunciones del sistema inmunológico como posibles desencadenantes. El diagnóstico de la rosácea es clínico y se basa en la evaluación de los signos y síntomas característicos. El manejo de esta afección requiere un enfoque individualizado que considere la gravedad de los síntomas y las necesidades del paciente. Las opciones terapéuticas actuales incluyen tratamientos tópicos como metronidazol, ácido azelaico e ivermectina; así como terapias sistémicas con antibióticos orales y, en casos severos, isotretinoína. Además, los procedimientos láser y de luz pulsada intensa han demostrado eficacia en la reducción del enrojecimiento persistente y las telangiectasias. La educación del paciente sobre los factores desencadenantes y el cuidado de la piel es esencial para un manejo exitoso. Este artículo revisa los avances recientes en el diagnóstico y tratamiento de la rosácea, proporcionando una guía práctica basada en la evidencia disponible.
Referências
Gallo RL, Granstein RD, Kang S, et al. Rosacea and its association with other systemic disorders: An update. J Am Acad Dermatol. 2016;74(5):765-773. doi:10.1016/j.jaad.2015.10.047
Schaller M, Almeida LMC, Bewick M, et al. Rosacea treatment update: Recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):465-471. doi:10.1111/bjd.14955
Thiboutot DM, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: The 2019 update from the American Acne and Rosacea Society. J Clin Aesthet Dermatol. 2019;12(6):38-45. doi:10.25251/skin.3.4.3
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749-758. doi:10.1016/j.jaad.2014.08.028
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761-770. doi:10.1016/j.jaad.2014.08.029
Van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for rosacea: Updated Cochrane systematic review and meta-analysis. Br J Dermatol. 2015;172(3):640-645. doi:10.1111/bjd.13465
Holmes AD, Spoendlin J, Chien AL, et al. Evidence-based updates on the pathophysiology, diagnosis, and treatment of rosacea: A systematic review of the literature from 2011 to 2020. J Am Acad Dermatol. 2021;84(2):451-460. doi:10.1016/j.jaad.2020.05.121
Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment strategies in the era of advanced bioinformatics and genomics research. J Invest Dermatol Symp Proc. 2018;19(2):S20-S26. doi:10.1016/j.jisp.2017.09.001
Egeberg A, Hansen PR, Gislason GH, et al. Risk of depression in patients with rosacea: A nationwide cohort study in Denmark. Br J Dermatol. 2016;175(4):797-804. doi:10.1111/bjd.14662
Tan J, Berg M, Stein Gold L, et al. Prospective study of the efficacy and safety of oxymetazoline cream 1% for treatment of persistent facial erythema associated with rosacea: Findings from two phase 3 trials and a long-term safety trial. J Am Acad Dermatol. 2018;78(3):603-610.e8. doi:10.1016/j.jaad.2017.11.042
Steinhoff M, Schmelz M, Schauber J, et al. Neurovascular and neuroimmune mechanisms in the pathophysiology of rosacea: A comprehensive review of current knowledge and future perspectives for treatment development. Exp Dermatol. 2016;25(2):137-144. doi:10.1111/exd.12948
Tan J, Liu H, Leyden JJ, et al. Management of rosacea: A tailored approach to patient care using combination therapy strategies based on phenotype severity and impact on quality of life outcomes in clinical practice settings worldwide—Expert consensus recommendations from the ROSCO panel meeting 2020 update report on rosacea management guidelines globally endorsed by dermatology societies worldwide including the American Academy of Dermatology (AAD). J Clin Aesthet Dermatol. 2020;13(5):S3-S14.
Del Rosso JQ, Thiboutot D, Gallo RL, et al. Consensus recommendations from the American Acne and Rosacea Society on the management of rosacea part 2: A status report on topical agents approved for treatment of rosacea and emerging therapeutic options for improving facial erythema and papulopustular lesions associated with rosacea in clinical practice settings globally—Findings from the ROSCO panel meeting 2019 update report endorsed by dermatology societies worldwide including the American Academy of Dermatology (AAD). J Clin Aesthet Dermatol 2020;13(5):S15-S24.
Schaller M, Almeida LMC, Bewick M, et al.; ROSCO Panel Members (ROSCO Panel Meeting Consensus Recommendations for Management of Rosacea Phenotypes Globally Endorsed by Dermatology Societies Worldwide Including AAD). Br J Dermatol 2020;182(2):465–471.
Draelos ZD, Maza A, Gold MH, et al. The efficacy of ivermectin cream 1% in papulopustular rosacea: Results from two randomized controlled trials and an open-label extension study over one year of treatment duration. J Drugs Dermatol. 2017;16(6):605-612.
11. Two AM, Wu W, Gallo RL, et al. Rosacea pathogenesis and treatment options: Advances in understanding and management strategies over the last decade. J Clin Med. 2021;10(2):318-330. doi:10.3390/jcm10020318
Del Rosso, J. Q., & Thiboutot, D. (2013). Management of rosacea: practical considerations and updates. Journal of Clinical and Aesthetic Dermatology 6(11), 30–40. https://doi.org/10.25251/2.2013.rosacea
Scharschmidt, T., & Yost, J. (2016). Nonpharmacologic management of rosacea: Current insights and evidence-based approaches. Dermatology and Therapy, 6(2), 225–236. https://doi.org/10.1007/s13555-016-0123-8
1. Thibaut de Menonville, T., & Dreno, B. (2019). Current and New Treatments in Rosacea: What's in the Pipeline? American Journal of Clinical Dermatology, 20(3), 305–316. https://doi.org/10.1007/s40257-019-00434-0
Semenescu I, Similie D, Diaconeasa Z, Danciu C. Recent Advances in the Management of Rosacea through Natural Compounds. Pharmaceuticals (Basel). 2024 Feb 6;17(2):212. doi: 10.3390/ph17020212.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Jimmy Jean Prado Soto, Ana Lucila Vaca Almendariz, Cristina Jaqueline Ruiz Vaca, Ivana Paola Zapata Tapia, Bryan Enrique Medina Agama, Karen Vanessa Acosta Salazar, Jennifer Vanessa Campoverde Ñauta, Estefanía Gabriela Viscarra Ordóñez
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
